GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Gross-Profit-to-Asset %

Asiatic Laboratories (DHA:ASIATICLAB) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Asiatic Laboratories's annualized Gross Profit for the quarter that ended in . 20 was BDT Mil. Asiatic Laboratories's average Total Assets over the quarter that ended in . 20 was BDT 0 Mil. Therefore, Asiatic Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.


Asiatic Laboratories Gross-Profit-to-Asset % Historical Data

The historical data trend for Asiatic Laboratories's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Gross-Profit-to-Asset % Chart

Asiatic Laboratories Annual Data
Trend
Gross-Profit-to-Asset %

Asiatic Laboratories Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Asiatic Laboratories's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Asiatic Laboratories's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asiatic Laboratories's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asiatic Laboratories's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Asiatic Laboratories's Gross-Profit-to-Asset % falls into.



Asiatic Laboratories Gross-Profit-to-Asset % Calculation

Asiatic Laboratories's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Asiatic Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Asiatic Laboratories Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines